WHO ICTRP trial
Effect of adding supermint and camellia sinensis to the routine treatment of…
IRCT20200422047167N1 · Iranian Registry of Clinical Trials (IRCT) · Not Recruiting
Key facts
| Trial ID | IRCT20200422047167N1 |
|---|---|
| Public title | Effect of adding supermint and camellia sinensis to the routine treatment of patients with helicobacter pylori infection |
| Scientific title | Effect of adding supermint and camellia sinensis to the routine treatment of patients with helicobacter pylori infection a double-blind clinical trial study |
| Primary sponsor | Shiraz University of Medical Sciences |
| Registry | Iranian Registry of Clinical Trials (IRCT) |
| Recruitment status | Not Recruiting |
| Study type | interventional |
| Phase | 3 |
| Countries | Iran (Islamic Republic of) |
| Conditions | Helicobacter pylori infection. |
| Interventions | Intervention 1: Intervention group: In addition to standard treatment, patients in this group will also take two herbal medicines, Camellia sinensis (green tea) and Supermint (mint tablets), for one month. Intervention 2: Control group… |
| Registration date | Dec 5, 2025 |
| Target size | 40 |
| Registry page | irct.behdasht.gov.ir |
At a glance
- No Results available
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About WHO ICTRP trial registrations
The WHO ICTRP combines trial registrations from primary registries worldwide into a single searchable index. Contact and ethics-committee details are not shown here.
Source: World Health Organization (WHO), International Clinical Trials Registry Platform (ICTRP) · Source date: